Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rejuvenated Autologous Blood Transfusion on VO2 Max
NCT03089047Phase 4Terminated
- Sponsor
- Duke University
- Start
- Sep 2017
- Primary completion
- Apr 2018
- Modality
- Injectable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rejuvesol in anemia, sponsored by Duke University. Started Sep 2017; status: terminated.
02
Drugs
rejuvesol
03
Conditions
anemia
Beyond the preview
Go deeper on NCT03089047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03089047.